News
Leidos Holdings, Inc. (NYSE:LDOS) is one of the 10 undervalued tech stocks flying under Wall Street’s radar. On June 23, ...
Equity Residential (NYSE:EQR) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on EQR with a ...
Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) is one of the most undervalued stocks. On June 5, Stifel analysts ...
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...
The $1.5 billion settlement in 2003 and 2004 addressed a scandal over analysts issuing positive research to help Citigroup, ...
Stifel co-president Nesi to retire, join board as Institutional Group revenue soars under his tenure
One of the financial services company's top investment bankers is retiring after 16 years, but he'll still have a role with ...
According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.25%, which ...
Oracle (ORCL) shares rose more than 6% on Monday after CEO Safra Catz touted a "strong start" to fiscal 2026 and investment ...
Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...
Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ:VTGN) with an unchanged price target of $12.00 post the company’s fiscal 2025 announcement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results